Full text is available at the source.
Abstract
Thirty-two randomized controlled studies were analyzed, revealing that LMWH is associated with a higher rate of VTE than factor Xa inhibitors in total knee and hip arthroplasty patients.
- LMWH provided better protection against VTE than placebo.
- Factor Xa inhibitors resulted in lower rates of VTE compared to LMWH in both TKA and THA patients.
- In THA patients, the rate of deep vein thrombosis (DVT) was lower with factor Xa inhibitors than LMWH.
- In TKA patients, the rates of VTE and DVT were similar between LMWH and direct thrombin inhibitors.
- Direct thrombin inhibitors were associated with a lower rate of VTE in THA patients, but had similar effectiveness to LMWH concerning DVT and pulmonary embolism.
Simplified